Jan 3, 2022 The US Food and Drug Administration has recently granted Emergency Use Authorization(EUA) for two oral medications to treat mild to moderate COVID-19: Nirmatrelvir with ritonavir (brand name Paxlovid) Molnupiravir.
At Yale Health we are continually reviewing the status of the pandemic and adjusting our precautionary policies to reflect the current public health situation. I write with reminders for you about the policies we have in place and also to update you on new changes in our practice.
Aug 19, 2021: The U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUAs) for both the Pfizer and Moderna COVID-19 vaccines to allow for the use of an additional dose in certain immunocompromised individuals.